
Overview
Navkiranjit (Sonika) Gill, DO, is a medical oncologist and hematologist. She sees all adult hematology and oncology patients.
Dr. Gill is highly rated in 12 conditions, according to our data. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Immune Thrombocytopenic Purpura (ITP).
Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8775 Norwin Avenue, Suite J, North Huntingdon, PA 15642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is highly rated in 23 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
Frequently Asked Questions about Dr. Navkiranjit K. Gill
Is Dr. Navkiranjit K. Gill a top-rated expert for Angiosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Navkiranjit K. Gill is classified as an Advanced expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Navkiranjit K. Gill specialize in?
While Dr. Navkiranjit K. Gill is a Hematology Oncology, they have specific expertise in Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Navkiranjit K. Gill participate in research or clinical trials?
Yes. Dr. Navkiranjit K. Gill has published 3 articles and abstracts on conditions like Angiosarcoma. You can view a list of Dr. Navkiranjit K. Gill's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Navkiranjit K. Gill accept my insurance?
Dr. Navkiranjit K. Gill accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Immune ThrombocytopeniaDr. Gill isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AngiosarcomaDr. Gill isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Gill isAdvanced. Learn about Breast Cancer.
- Colorectal CancerDr. Gill isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Gill isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Gill isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- AgranulocytosisDr. Gill isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Gill isExperienced. Learn about Anemia.
- Chronic Familial NeutropeniaDr. Gill isExperienced. Learn about Chronic Familial Neutropenia.
- EGFR Positive Lung CancerDr. Gill isExperienced. Learn about EGFR Positive Lung Cancer.
- Gastric LymphomaDr. Gill isExperienced. Learn about Gastric Lymphoma.



